Metastatic melanoma: Newer TKIs and immune checkpoint inhibitors lead the way in survival
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- In an explorative analysis of different studies in metastatic melanoma, the optimal survival outcomes were observed with combination BRAF and MEK inhibition, or immune checkpoint inhibition.
- Explorative analysis comparing survival data from different clinical tria...